| |
|
|
|
|
|
|
|||
|
Blood, 1 January 2006, Vol. 107, No. 1, pp. 250-256. Prepublished online as a Blood First Edition Paper on September 13, 2005; DOI 10.1182/blood-2005-03-1194.
NEOPLASIA Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignanciesFrom the Breakthrough Breast Cancer Centre, Institute of Cancer Research, London, United Kingdom; Ludwig Institute for Cancer Research, University College London, London, United Kingdom; Beatson Institute for Cancer Research, Growth Factor Signalling Laboratory, Garscube Estate, Bearsden, Glasgow, United Kingdom; Medical Research Council Toxicology Unit, University of Leicester Medical School, Leicester, United Kingdom; Department of Virology, Imperial College Faculty of Medicine, St Mary's Campus, London, United Kingdom; Cell Cycle Control and Carcinogenesis, F045, German Cancer Research Center DKFZ, Heidelberg, Germany; Department of Veterinary Pathology, University of Edinburgh, Edinburgh, United Kingdom.
The Polo-like kinases (Plks) are a highly conserved family of protein kinases that function in regulation of cell cycle and DNA damage-induced checkpoints. Evidence of a tumor suppressor function for the Plks in human neoplasia is lacking. Here, we report that Snk/Plk2 is transcriptionally down-regulated in B-cell neoplasms. Silencing occurs with very high frequency in Burkitt lymphoma (BL) but is also detected in B-cell neoplasms of other types and is associated with aberrant cytosine methylation in the CpG island located at the 5' end of the SNK/PLK2 gene. Silencing is specific to malignant B cells because SNK/PLK2 was unmethylated (and expressed) in primary B lymphocytes, in EBV-immortalized B lymphoblastoid cell lines (LCLs), and in adenocarcinomas (of the breast) and squamous-cell carcinomas (of the head and neck). Expression of Snk/Plk2 in BL cell lines was restored by demethylating agents. The related PLK1 and PLK3 (FNK/PRK) genes were overexpressed in BL cell lines lacking Snk/Plk2 expression, consistent with functional degeneracy among the Plk family. Ectopic expression of Snk/Plk2 in BL cells resulted in apoptosis, a potential mechanistic basis underlying the strong selective pressure for abrogation of Snk/Plk2 function in B-cell neoplasia.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||